Letrozole, marketed as Femara and approved by the FDA in 1997, is a third-generation aromatase inhibitor mainly used to reduce estrogen levels in postmenopausal women with breast cancer. However, it’s also popular among bodybuilders who use it to manage estrogen levels during steroid cycles and avoid side effects like gynecomastia (enlarged breast tissue)
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Letrozole 2.5 by Hilma Biocare, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.